Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study

<i>Background and Objectives:</i> Acute ischemic stroke is a major cause of disability and mortality. Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery. This study evaluated the impact of adding Cerebrolysin to standard therap...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Geetha Kandasamy, Vijayakumar Arumugam, Khalid Orayj, Asma M. Alshahrani, Tahani S. Alanazi, Amjad Hmlan, Jithin P. Venugopal
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	acute ischemic stroke cerebrolysin Barthel index functional outcome NIH stroke scale adjuvant therapy
Online Access:	https://www.mdpi.com/1648-9144/61/9/1531